In the past three years, the share price of SomnoMed Limited ( ASX:SOM ) has struggled to grow and now shareholders are...
Looking at SomnoMed Limited's ( ASX:SOM ) insider transactions over the last year, we can see that insiders were net...
SomnoMed Limited (ASX "SOM", or the Company), a leading company in the provision of oral appliance treatment solutions for sleep-related breathing disorders and obstructive sleep apnea ('OSA'), is pleased to provide its quarterly activities report for the period ended 30 September 2022 (Q1 FY23).